Skip to content

Drug interactions

Bosentan + Elvitegravir

Severity: Major

Bosentan and Elvitegravir: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elvitegravir is given with cobicistat, a strong CYP3A inhibitor that raises bosentan exposure. Bosentan may also lower elvitegravir levels through induction, risking virologic failure.

What this interaction means in plain words

Bosentan and Elvitegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Cobicistat inhibits CYP3A4 clearance of bosentan while bosentan induces CYP3A4, reducing elvitegravir levels.

What to do

Avoid if possible; if bosentan must be used with boosted elvitegravir, follow the bosentan washout and low-dose restart schedule and monitor liver enzymes and HIV viral load.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Elvitegravir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Bosentan with Elvitegravir?

MediHelp rates the interaction as major. Bosentan and Elvitegravir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Elvitegravir is given with cobicistat, a strong CYP3A inhibitor that raises bosentan exposure. Bosentan may also lower elvitegravir levels through induction, risking virologic failure.

How serious is the interaction between Bosentan and Elvitegravir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; if bosentan must be used with boosted elvitegravir, follow the bosentan washout and low-dose restart schedule and monitor liver enzymes and HIV viral load.

What other medicines interact with Bosentan?

MediHelp also lists interactions of Bosentan with, for example, Cyclosporin, Glibenclamide, Glyburide-metformin. The full list is on the Bosentan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in